Table 5 Comparisons between existing signatures and ours
From: Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Study | PMID | Number of CR genes | Model type | Predictive accuracy | Validation cohort | Focus of study | Experimental validation |
|---|---|---|---|---|---|---|---|
Zhang G et al | 35790864 | 10 | CR LncRNA | 0.719 | NA | Prognosis ICBs efficiency | NA |
Wang X et al | 36250008 | 16 | CR genes | 0.644 | 144 | Prognosis ICBs efficiency | NA |
Wang Y et al | 36065073 | 13 | CR genes | 0.691 | 115 | Prognosis | NA |
Zhang Q et al | 36153416 | 17 | CR LncRNA | 0.723 | 175 | Prognosis TIM | NA |
Zhang Z et al | 35898502 | FDX1-related | CR genes | 0.620 | 457 | Prognosis Sorafenib efficiency | NA |
Ours | NA | 17 | CR genes | 0.721 | 516 | Multi-omics | DLAT |